Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality

Published:2019-06-13 Issue:7 Volume:95 Page:936-939
ISSN:0955-3002
Container-title:International Journal of Radiation Biology
language:en
Short-container-title:International Journal of Radiation Biology

Author:

Ko Eric C.¹^ORCID,Formenti Silvia C.¹^ORCID

Affiliation:

1. Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA

Funder

Bristol-Myers Squibb, Eisai, Janssen, Merck, Regeneron, Varian

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09553002.2019.1623429

Reference28 articles.

1. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

2. The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive Immunity

3. The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling

4. Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients

5. Role of Local Radiation Therapy in Cancer Immunotherapy

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ANXA5 predicts prognosis and immune response and mediates proliferation and migration in head and neck squamous cell carcinoma;Gene;2024-12

2. Navigating the tumor microenvironment: mesenchymal stem cell-mediated delivery of anticancer agents;Journal of Drug Targeting;2024-05-06

3. Response of treatment-naive brain metastases to stereotactic radiosurgery;Nature Communications;2024-05-02

4. G-CSF improving combined whole brain radiotherapy and immunotherapy prognosis of non-small cell lung cancer brain metastases;International Immunopharmacology;2024-03

5. Chronomodulated chemotherapy for locoregionally advanced nasopharyngeal carcinoma: A phase II randomized controlled trial;Radiation Medicine and Protection;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3